BROMPHENIRAMINE;
ESTROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETYNODIOL DIACETATE;
ETYNODIOL DIACETATE PLUS MESTRANOL;
MESTRANOL;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
ADVERSE DRUG REACTION;
CASE REPORT;
CHOREA;
CHOREA MINOR;
CONGENITAL CYANOTIC HEART MALFORMATION;
DYSKINESIA;
INTOXICATION;
NERVOUS SYSTEM;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PURPURA;
THERAPY;
ACCEPTOR CHARACTERISTICS;
BIOLOGY;
CASE STUDIES;
CENTRAL NERVOUS SYSTEM;
CENTRAL NERVOUS SYSTEM EFFECTS;
CHOREA;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, ESTROGEN--ADMINISTRACTION AND DOSAGE;
CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE;
CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE;
CONTRACEPTIVE METHODS--SIDE EFFECTS;
DISEASES;
FAMILY PLANNING;
ORAL CONTRACEPTIVES--SIDE EFFECTS;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
SIGNS AND SYMPTOMS;
STUDIES;
Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents
Lai S, Sourkes TL: Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents. Arch Int Pharmacodyn Ther 199:289-301, 1972
Changes in brain monoamine concentrations during the oestrus cycle in the mouse: Possible pharmacologic implications
Greengrass PM, Tonge SR: Changes in brain monoamine concentrations during the oestrus cycle in the mouse: Possible pharmacologic implications. J Pharm Pharmacol 23:897-899, 1971
Roller WC, Weiner WJ, Klawans HL, et al: Sydenham chorea: An update. Presented at the 31st Annual Meeting of the American Academy of Neurology, Chicago, April 1979